Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $85.11 -1.42%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.36), $0.16 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $75.23 million versus the consensus estimate of $52.66 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Carter's (CRI) at Outperform
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
